Summary & Overview
CPT 83880: Quantitative Natriuretic Peptide Assay for Heart Failure
CPT code 83880 represents a quantitative laboratory assay for natriuretic peptide, a hormone released by cardiac muscle in response to increased wall stress. This biomarker is clinically important for diagnosing and managing congestive heart failure and is widely used in emergency, inpatient, and outpatient settings. Nationally, the test influences care pathways for patients presenting with dyspnea and contributes to risk stratification and treatment decisions in heart failure management.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the test’s clinical role and typical sites of service, along with coverage and reimbursement context across major payers. The publication summarizes common billing modifiers and related administrative considerations, presents benchmarks where available, and highlights policy updates that affect laboratory reimbursement and coding practice.
This report is intended for billing managers, laboratory directors, clinicians involved in heart failure care, and policy analysts seeking a clear, national-level briefing on the use and payer handling of CPT code 83880. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 83880 measures the concentration of natriuretic peptide, a hormone produced by heart muscle cells, in a patient blood specimen. This laboratory test is used to assess and monitor patients with suspected or known congestive heart failure by quantifying circulating levels of the peptide that rise with cardiac stress.
Service Type: Clinical laboratory test — quantitative natriuretic peptide assay
Typical Site of Service: Hospital laboratory, independent clinical laboratory, or outpatient laboratory collection site
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient presents to the emergency department with progressive shortness of breath, lower extremity edema, and fatigue. The emergency physician orders a blood test for natriuretic peptide measurement to evaluate for congestive heart failure. A phlebotomy technician collects a venous blood specimen; the specimen is labeled and sent to the hospital clinical laboratory. A medical laboratory scientist performs the assay to quantify B-type natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP) using an immunoassay platform. Results are reported to the ordering provider to assist in diagnosis, triage (admission vs. discharge), and monitoring response to therapy. Typical sites of service include the hospital inpatient laboratory, emergency department, and outpatient clinical laboratory. The service is billed when the quantitative measurement of natriuretic peptide is performed on the patient specimen to aid evaluation of heart failure or volume overload.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation or professional portion of a lab result if split billing applies (rare for automated assays). |
59 | Distinct procedural service |